Alibaba Health plans wider online sales push in China as competition heats up
08 July 2015
Alibaba Group Holdings ($BABA) aims for a controlling stake in HK-listed Alibaba Health Information Technology as it seeks to grow in a still-fragmented market in China for online drug sales that increasingly looks like a tough nut to crack as competition grows and regulatory approvals drag, theSouth China Morning Post reports.
Insurer M&A endangers pharma's pricing power, particularly in cancer: Moody's
08 July 2015
Drugmakers can't be excited about the wave of consolidation going through the health insurance business. After all, pharma knows firsthand how mergers can put the screws to prices; just think of Express Scripts ($ESRX) and its Medco buyout.
India's Lupin gets Russian production site in deal for Biocom
08 July 2015
While recent problems in Russia's economy have thrown some deals off course, Western drugmakers in the last several years have built or bought production capacity in Russia to tap what has been seen as an important emerging market. India's Lupin jumped into that market, picking up a company that will give it a production toehold there.
How The Feds Discourage Prescription Drug Competition
08 July 2015
There’s a growing refrain among those who pay for healthcare services that they want new products to deliver more value. When it comes to prescription drugs, this is usually interpreted to mean medicines that provide more benefit, at lower costs per increment of clinical advantage. Drugs that deliver more bang for the buck.
07 July 2015
Epic Sciences (Epic) announced today an agreement with Laboratory Corporation of America® Holdings (LabCorp®) to provide circulating tumor cell (CTC) technology and support oncology clinical trials in Asia through Covance Drug Development (Covance). Covance will process patient samples in Singapore, and then send samples to Epic's clinical laboratory in San Diego, which has recently been licensed under the Clinical Laboratory Improvement Amendments (CLIA) of 1988, for downstream detection and molecular characterization of CTCs. This agreement expands on a previous contract announced last year between Epic and LabCorp for European clinical trials.
HIV investigators at Harvard, J&J see promise in early-stage vaccine
07 July 2015
A team of collaborators drawn from Harvard, Johnson & Johnson ($JNJ) and other groups published results from a preclinical animal study Thursday afternoon that underscores the potential for developing the world's first HIV vaccine.
Clinical cancer research gets a boost from Japan's cabinet
07 July 2015
Clinical cancer research got a boost in Japan as the cabinet called for faster development of a patient registry from the National Cancer Center and 5 affiliated clinics as part of economic reforms aimed at lifting the country out of decades of deflation, the Japan Times said.
Nobel Prize winner purportedly “amazed” at high level of cancer R&D at Russian biotech firm
07 July 2015
James D. Watson, an American molecular biologist, geneticist and zoologist who in 1962 was awarded the Nobel Prize in physiology or medicine as the co-discoverer of the structure of DNA, on June 20, 2015 visited the laboratories of a Russian innovation company, Biocad. The Nobel Prize laureate “didn’t expect” to see how advanced Biocad’s anti-cancer solutions are, the Biocad website announced .
IBM and Russian partners want to create high tech personalized medicine in Russia
07 July 2015
IBM, Russia’s Skolkovo Foundation and the Moscow-based First Oncology Research and Advisory Center are forming a partnership to focus on the development of a platform for high tech personalized medicine in Russia, the Skolkovo Foundation website announced .
Published Data Support Scientific Basis for Ganaxolone Use in PCDH 19 Female Epilepsy
06 July 2015
Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative neuropsychiatric therapeutics, today announced that Jozef Gecz, Ph.D., Professor of Human Genetics at the Department of Pediatrics, University of Adelaide, published data in the June issue of Human Molecular Genetics, supporting the role for neurosteroids in the pathophysiology of PCDH19 female epilepsy.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024